Pneumonia Clinical Trial Landscape
Data updated: May 20, 2026
514 clinical trials tracked since 2008
Pneumonia is being studied across 514 clinical trials registered since 2008, with 94 programs currently active. The competitive pipeline includes 33 active Phase 3 trials, 31 active Phase 2 trials, and 15 active Phase 1 trials. Top industry sponsors include GSK, Qilu Pharmaceutical Co., Ltd., Pfizer.
94 active
/
514 total (since 2008)
15
Phase 1 Active
84 total
31
Phase 2 Active
186 total
33
Phase 3 Active
181 total
28
Phase 4 Active
122 total
Top Industry Sponsors
Sorted by active Active Done Failed
GSK 4 2 0
Qilu Pharmaceutical Co., Ltd. 2 0 0
Pfizer 1 11 3
Biotest 1 1 1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1 1 0
+ 10 more sponsors — see full table below
Featured Phase 3 Trials
NCT06710080 RECRUITING
Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia
Ottawa Heart Institute Research Corporation n=168
NCT07326540 RECRUITING
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
BioVersys SAS n=248
NCT07388680 RECRUITING
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Beijing Continent Pharmaceutical Co, Ltd. n=298
NCT05848713 RECRUITING
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
University of Manitoba n=4,000
+ 176 more Phase 3 trials — see full database below
Pneumonia — Trials Started by Year (last 10 years)
2016 23
2017 15
2018 19
2019 20
2020 96
2021 48
2022 26
2023 25
2024 23
2025 27
2026 29
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
GSK 6
Qilu Pharmaceutical Co., Ltd. 2
Pfizer 15
Biotest 3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2
BioVersys AG 2
BioVersys SAS 1
MicrobiotiX Co., Ltd 1
Beijing Continent Pharmaceutical Co, Ltd. 1
Omnix Medical Ltd 1
Active Trials by Phase
Phase 1 15
Phase 2 31
Phase 3 33
Phase 4 28
Enrollment Size Distribution
1-50 141
51-200 145
201-500 98
501-1k 49
1k+ 46
All Industry Sponsors
Sorted by active Active Done Failed
GSK 4 2 0
Qilu Pharmaceutical Co., Ltd. 2 0 0
Pfizer 1 11 3
Biotest 1 1 1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1 1 0
BioVersys AG 1 1 0
BioVersys SAS 1 0 0
MicrobiotiX Co., Ltd 1 0 0
Beijing Continent Pharmaceutical Co, Ltd. 1 0 0
Omnix Medical Ltd 1 0 0
Vasomune Therapeutics, Inc. 1 0 0
Eagle Pharmaceuticals, Inc. 1 0 0
Synairgen Research Ltd. 1 0 0
Op-T LLC 1 0 0
Dr. Md. Alimur Reza 1 0 0
NCT06710080 RECRUITING
Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia
Ottawa Heart Institute Research Corporation n=168
NCT07326540 RECRUITING
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
BioVersys SAS n=248
NCT07388680 RECRUITING
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Beijing Continent Pharmaceutical Co, Ltd. n=298
NCT05848713 RECRUITING
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
University of Manitoba n=4,000
NCT07530146 RECRUITING
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
Helwan University n=41
NCT06592586 ACTIVE NOT RECRUITING
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Minervax ApS n=338
NCT06229288 RECRUITING
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
Nantes University Hospital n=326
NCT05722938 RECRUITING
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Biotest n=590
NCT06488794 NOT YET RECRUITING
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
University Hospital Fattouma Bourguiba n=400
NCT04851015 RECRUITING
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
Todd C. Lee MD MPH FIDSA n=416
NCT07327619 RECRUITING
A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Qilu Pharmaceutical Co., Ltd. n=420
NCT06294600 RECRUITING
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
Hellenic Institute for the Study of Sepsis n=330
NCT04948203 ACTIVE NOT RECRUITING
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
University of Chicago n=60
NCT06134492 RECRUITING
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Jena University Hospital n=616
NCT05843786 RECRUITING
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Hospices Civils de Lyon n=132
NCT06774846 NOT YET RECRUITING
Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
Centre Hospitalier Universitaire Dijon n=600
NCT07152613 NOT YET RECRUITING
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
Qingyuan Zhan n=240
NCT07152587 NOT YET RECRUITING
Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)
Qingyuan Zhan n=1,500
NCT06269900 RECRUITING
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype
Nantes University Hospital n=450
NCT07089186 RECRUITING
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
Qilu Pharmaceutical Co., Ltd. n=80
NCT05696093 RECRUITING
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
Assistance Publique - Hôpitaux de Paris n=628
NCT03031210 RECRUITING
Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
St. Justine's Hospital n=1,370
NCT05903352 RECRUITING
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
Assistance Publique - Hôpitaux de Paris n=328
NCT06859450 NOT YET RECRUITING
Local Antibiotic Delivery for Community Acquired Pneumonia
Copenhagen Respiratory Research n=36
NCT04256798 RECRUITING
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
University of Birmingham n=12,942
NCT06815679 NOT YET RECRUITING
Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC
Università degli Studi di Ferrara n=20
NCT06815549 NOT YET RECRUITING
An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation n=280
NCT06296212 RECRUITING
Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.
Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica n=178
NCT03581370 RECRUITING
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
University Hospital, Toulouse n=80
NCT02735707 RECRUITING
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
UMC Utrecht n=20,000
NCT06162286 RECRUITING
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Zai Lab (Hong Kong), Ltd. n=100
NCT05706454 RECRUITING
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
KARE Biosciences n=324
NCT07492875 WITHDRAWN
Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia
ImmunityBio, Inc.
NCT05905055 COMPLETED
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Meiji Seika Pharma Co., Ltd. n=126
NCT05254990 TERMINATED
Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia
Dompé Farmaceutici S.p.A n=414
NCT02517489 COMPLETED
Community-Acquired Pneumonia : Evaluation of Corticosteroids
University Hospital, Tours n=952
NCT03149640 COMPLETED
Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
University Hospital, Tours n=850
NCT05204563 COMPLETED
Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)
Evopoint Biosciences Inc. n=450
NCT05526716 COMPLETED
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)
Merck Sharp & Dohme LLC n=1,080
NCT03915366 COMPLETED
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Hospital Universitario 12 de Octubre n=563
NCT06168734 WITHDRAWN
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Venatorx Pharmaceuticals, Inc.
NCT05531149 TERMINATED
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Biotest n=107
NCT04779242 COMPLETED
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
Paratek Pharmaceuticals Inc n=670
NCT06263881 COMPLETED
Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia
Materia Medica Holding n=370
NCT04884490 COMPLETED
The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh n=94
NCT05331885 TERMINATED
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Aridis Pharmaceuticals, Inc. n=24
NCT03474991 COMPLETED
KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP
Julia Bielicki n=510
NCT03583333 COMPLETED
Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
Merck Sharp & Dohme LLC n=274
NCT06739382 COMPLETED
Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center
Beni-Suef University n=64
NCT03329092 COMPLETED
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
Pfizer n=422
NCT05077917 TERMINATED
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
Texas Tech University Health Sciences Center, El Paso n=22
NCT05420961 COMPLETED
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
Merck Sharp & Dohme LLC n=717
NCT04041791 COMPLETED
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
University of Oxford n=4,392
NCT05713292 COMPLETED
Pirfenidone in Adult Hospitalized Patients With COVID-19
Capital Medical University n=168
NCT05485051 COMPLETED
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
Hospital do Coracao n=15,730
NCT04878055 COMPLETED
Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
Dompé Farmaceutici S.p.A n=287
NCT04449588 TERMINATED
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
Staidson (Beijing) Biopharmaceuticals Co., Ltd n=369
NCT04970719 WITHDRAWN
Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
NCT03382548 COMPLETED
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
University of Oxford n=460
NCT04794803 TERMINATED
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
Dompé Farmaceutici S.p.A n=56
NCT04724044 COMPLETED
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
Hellenic Institute for the Study of Sepsis n=278
NCT05895773 COMPLETED
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Menoufia University n=78
NCT05656443 COMPLETED
Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19
Fujian Akeylink Biotechnology Co., Ltd. n=1,246
NCT04629703 COMPLETED
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Rigel Pharmaceuticals n=280
NCT02389036 COMPLETED
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
The George Institute n=20,010
NCT03816956 COMPLETED
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
Aridis Pharmaceuticals, Inc. n=174
NCT04439071 TERMINATED
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
PTC Therapeutics n=189
NCT04917523 COMPLETED
Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above
China National Biotec Group Company Limited n=1,800
NCT04333420 COMPLETED
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia
InflaRx GmbH n=399
NCT03439124 COMPLETED
Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
Basilea Pharmaceutica n=138
NCT05822180 COMPLETED
Evaluation of the Efficacy and Safety of Nano-S1
General Administration of Military Health, Tunisia n=116
NCT03551210 COMPLETED
Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia
R-Pharm n=342
NCT04372186 COMPLETED
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
Genentech, Inc. n=377
NCT03894046 COMPLETED
Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex
Entasis Therapeutics n=207
NCT04071041 TERMINATED
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
Jordi Carratala n=39
NCT01597973 COMPLETED
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
University of Michigan n=467
NCT04643678 COMPLETED
Anakinra in the Management of COVID-19 Infection
Hamad Medical Corporation n=80
NCT04345289 TERMINATED
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
Thomas Benfield n=147
NCT04535063 COMPLETED
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno n=200
NCT04621058 COMPLETED
Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.
Bioaraba Health Research Institute n=108
NCT05445089 COMPLETED
Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients
Instituto Venezolano de Investigaciones Cientificas n=600
NCT05417997 COMPLETED
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
RAAS Nutritionals, LLC n=71
NCT04369469 TERMINATED
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia
Alexion Pharmaceuticals, Inc. n=202
NCT03896477 COMPLETED
Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants
PATH n=660
NCT04901689 SUSPENDED
Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
Hospital Israelita Albert Einstein n=316
NCT04901676 SUSPENDED
Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
Hospital Israelita Albert Einstein n=612
NCT05262309 COMPLETED
An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19
Fondazione Policlinico Universitario Agostino Gemelli IRCCS n=42
NCT04409262 COMPLETED
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
Hoffmann-La Roche n=649
NCT04362813 COMPLETED
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
Novartis Pharmaceuticals n=454
NCT04345861 TERMINATED
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
University Hospital, Montpellier n=7
NCT02205112 COMPLETED
A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
TaiGen Biotechnology Co., Ltd. n=598
NCT04346693 COMPLETED
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Burnasyan Federal Medical Biophysical Center n=320
NCT03829618 TERMINATED
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
Milton S. Hershey Medical Center n=29
NCT04372589 COMPLETED
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
University of Manitoba n=1,200
NCT03749226 TERMINATED
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
Hospital Universitari Joan XXIII de Tarragona. n=9
NCT04320615 COMPLETED
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia
Hoffmann-La Roche n=452
NCT03545373 COMPLETED
Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)
London School of Hygiene and Tropical Medicine n=1,583
NCT03950856 COMPLETED
Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)
Merck Sharp & Dohme LLC n=2,340
NCT02265406 COMPLETED
PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone
Poitiers University Hospital n=354
NCT04347031 COMPLETED
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
Burnasyan Federal Medical Biophysical Center n=320
NCT04321278 COMPLETED
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
Hospital Israelita Albert Einstein n=440
NCT02714595 COMPLETED
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
Shionogi n=152
NCT03345992 COMPLETED
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
Hellenic Institute for the Study of Sepsis n=110
NCT04675086 WITHDRAWN
Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
Blessing Corporate Services, Inc
NCT04381858 COMPLETED
Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia
Centenario Hospital Miguel Hidalgo n=196
NCT03032380 COMPLETED
Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
Shionogi n=300
NCT04500067 COMPLETED
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
Biopharma Plasma LLC n=76
NCT04403685 TERMINATED
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Beneficência Portuguesa de São Paulo n=129
NCT04327401 TERMINATED
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
Hospital Sirio-Libanes n=299
NCT03197376 COMPLETED
Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants
PATH n=2,250
NCT04347512 WITHDRAWN
EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA
University Hospital, Strasbourg, France
NCT02494999 COMPLETED
A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
Jiangsu Province Centers for Disease Control and Prevention n=1,200
NCT02070757 COMPLETED
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) n=726
NCT02493764 COMPLETED
Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Merck Sharp & Dohme LLC n=537
NCT04261517 COMPLETED
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
Shanghai Public Health Clinical Center n=30
NCT02186951 COMPLETED
Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications
University Hospital, Limoges n=197
NCT02679573 COMPLETED
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=860
NCT04278248 COMPLETED
Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd n=1,940
NCT02943902 COMPLETED
Reduced PCV Dosing Schedules in South African Infants
University of Witwatersrand, South Africa n=600
NCT02559310 COMPLETED
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
Nabriva Therapeutics AG n=551
NCT02813694 COMPLETED
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Nabriva Therapeutics AG n=738
NCT02134106 WITHDRAWN
Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria
Tan Tock Seng Hospital
NCT03409679 TERMINATED
Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa
Polyphor Ltd. n=41
NCT03582007 TERMINATED
Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
Polyphor Ltd. n=2
NCT02019420 COMPLETED
Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) n=726
NCT02168946 COMPLETED
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) n=77
NCT02531438 COMPLETED
Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
Paratek Pharmaceuticals Inc n=774
NCT03006679 WITHDRAWN
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Melinta Therapeutics, Inc.
NCT02605122 TERMINATED
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=97
NCT02080754 COMPLETED
Sellick Interest in Rapid Sequence Induction
Assistance Publique - Hôpitaux de Paris n=3,472
NCT01853982 TERMINATED
Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) n=4
NCT01446874 TERMINATED
Prevention of Post-operative Pneumonia (POPP)
Washington University School of Medicine n=150
NCT01970371 COMPLETED
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
Achaogen, Inc. n=69
NCT02906722 TERMINATED
Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia
Assistance Publique - Hôpitaux de Paris n=7
NCT03622450 COMPLETED
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
Nourhan Hassan Osama Thuraya Mohamed n=40
NCT02806141 TERMINATED
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
Hat Yai Medical Education Center n=204
NCT01799993 COMPLETED
Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Bayer n=725
NCT00707941 COMPLETED
Oseltamivir Randomised Controlled Efficacy Trial
International Centre for Diarrhoeal Disease Research, Bangladesh n=1,190
NCT01319955 COMPLETED
Flu Vaccine Against Childhood Pneumonia, Bangladesh
International Centre for Diarrhoeal Disease Research, Bangladesh n=3,508
NCT01093261 COMPLETED
Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury
Nantes University Hospital n=336
NCT01371838 COMPLETED
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Pfizer n=848
NCT01808092 COMPLETED
A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
Pfizer n=969
NCT03208361 TERMINATED
Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina n=43
NCT01138540 TERMINATED
The Gravity-VAP (Ventilator-Associated Pneumonia) Trial
Policlinico Hospital n=800
NCT00621504 COMPLETED
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Forest Laboratories n=606
NCT01756339 COMPLETED
Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=860
NCT01968733 COMPLETED
Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. n=863
NCT01633294 COMPLETED
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
Hospital de Santa Maria, Portugal n=161
NCT01292031 COMPLETED
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla n=232
NCT02269644 WITHDRAWN
A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
Durata Therapeutics Inc., an affiliate of Allergan plc
NCT02139228 COMPLETED
Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children
Novartis Vaccines n=426
NCT01868113 COMPLETED
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
Makerere University n=1,010
NCT01561794 COMPLETED
A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Bayer n=44
NCT01648777 COMPLETED
Catheter Outcomes With Sternotomy Cardiac Operated
Assistance Publique - Hôpitaux de Paris n=1,502
NCT00973154 COMPLETED
Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial
University Hospital, Basel, Switzerland n=800
NCT01399723 COMPLETED
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
KEMRI-Wellcome Trust Collaborative Research Program n=561
NCT01530763 COMPLETED
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
Forest Laboratories n=161
NCT01014364 TERMINATED
Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
University of Versailles n=40
NCT00717561 COMPLETED
A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
Bayer n=60
NCT01110421 TERMINATED
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
Janssen Research & Development, LLC n=7
NCT01605864 COMPLETED
Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Albany Medical College n=12
NCT01057758 TERMINATED
STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated Pneumonia
Assistance Publique Hopitaux De Marseille n=300
NCT01529476 COMPLETED
Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP
TaiGen Biotechnology Co., Ltd. n=540
NCT01602874 WITHDRAWN
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
Pfizer
NCT01477723 TERMINATED
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
Abbott Nutrition n=17
NCT00589693 TERMINATED
To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. n=274
NCT00705445 COMPLETED
Evaluation of Zinc and / or Micronutrient Supplementation on Intestinal Flora, Diarrheal Disease Burden, Intestinal Mucosal Integrity and Growth Among Children of Pakistan
Aga Khan University n=2,745
NCT01189487 COMPLETED
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
Pfizer n=47
NCT00950027 TERMINATED
Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care Unit
Rennes University Hospital n=179
NCT00914888 WITHDRAWN
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
Wyeth is now a wholly owned subsidiary of Pfizer
NCT01577862 COMPLETED
Colistin and Rifampicin for MDR-Acinetobacter
University of Campania Luigi Vanvitelli n=210
NCT00809328 COMPLETED
The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)
Pfizer n=102
NCT00798278 COMPLETED
Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood
Spanish Society of Pediatric Surgery n=200
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only